OMX Ventures
Venture capitalLincolnshire · Seed–Series A · 4 people tracked
Investment thesis
OMX Ventures is an early-stage venture capital firm investing in bioengineering companies that apply biology, data science, and artificial intelligence to develop therapeutics, diagnostics, tools, and synthetic biology platforms. The firm targets companies developing bioengineered solutions across medicine, food, industrial products, and related sectors.
Team · 4 people
from the firm's websiteFrequently asked questions
- What stage does OMX Ventures invest at?
- OMX Ventures invests at the Seed, Series A stages.
- What sectors does OMX Ventures focus on?
- OMX Ventures focuses on Biotech, Medical Devices.
- Where is OMX Ventures located?
- OMX Ventures is headquartered in Lincolnshire, US.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.